Leaf Energy’s objective is to become a global market leader in the development, adoption and application of technology and know-how for the production of biofuels and plant-made compounds for use in medical research, therapeutic and industrial markets.
Leaf Energy Limited is an Australian ASX listed company which holds the worldwide exclusive rights to commercialise INPACT, a sophisticated technology developed by leading researchers at the Queensland University of Technology (QUT). Together with a number of additional patented technologies within its portfolio, Leaf Energy intends to utilise plants as 'factories' for the cost efficient and effective production of biofuels and proteins in the high-value medical research, industrial and therapeutic markets.
In 2011, Leaf Energy’s aim is to commercialise its first plant-based protein "Vitronectin". Vitronectin is an extracellular matrix protein currently extracted from human plasma and used as a coating for tissue culture plates. It has potential applications in many areas of medical research including its use in mammalian tissue culture media, wound healing, cancer therapy, biomimetics, disease pathogenesis.
The company is also in the process of profiling and selecting additional protein candidates for entry into the product development pipeline and continues to maintain its contribution to the Syngenta AG, QUT and Leaf Energy biofuels collaboration.
In addition, Leaf Energy controls two high ground mining leases of approximately 158 hectares, which are expected to generate intermittent revenue from the sale of gravel from its joint venture located at Karratha (WA).